Pablo Berríos‐Cárcamo

423 total citations
21 papers, 303 citations indexed

About

Pablo Berríos‐Cárcamo is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Pablo Berríos‐Cárcamo has authored 21 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Pablo Berríos‐Cárcamo's work include Neurotransmitter Receptor Influence on Behavior (6 papers), Receptor Mechanisms and Signaling (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Pablo Berríos‐Cárcamo is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (6 papers), Receptor Mechanisms and Signaling (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Pablo Berríos‐Cárcamo collaborates with scholars based in Chile, United States and Italy. Pablo Berríos‐Cárcamo's co-authors include Mario Herrera‐Marschitz, Marı́a Elena Quintanilla, Yedy Israel, Paola Morales, Marcelo Ezquer, Mario Rivera‐Meza, Fernando Ezquer, Daniela Santapau, Bruce K. Cassels and Belén Olivares and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Drug and Alcohol Dependence.

In The Last Decade

Pablo Berríos‐Cárcamo

20 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Berríos‐Cárcamo Chile 10 153 74 59 55 47 21 303
Jianbo Zhang China 11 84 0.5× 114 1.5× 53 0.9× 44 0.8× 40 0.9× 23 374
Sheng‐Yang Huang Taiwan 10 67 0.4× 98 1.3× 98 1.7× 66 1.2× 18 0.4× 18 374
Letícia Pereira Brazil 11 115 0.8× 116 1.6× 97 1.6× 65 1.2× 25 0.5× 15 399
Laura Sánchez‐Marín Spain 12 65 0.4× 71 1.0× 40 0.7× 34 0.6× 49 1.0× 20 255
Teresa Canedo Portugal 8 100 0.7× 90 1.2× 178 3.0× 54 1.0× 66 1.4× 13 356
Malk Eun Pak South Korea 12 61 0.4× 68 0.9× 107 1.8× 38 0.7× 23 0.5× 24 306
Ana Gavito Spain 12 82 0.5× 66 0.9× 44 0.7× 93 1.7× 42 0.9× 31 376
Liu-kun Yang China 12 82 0.5× 107 1.4× 47 0.8× 97 1.8× 49 1.0× 15 329
Mario Rivera‐Meza Chile 14 268 1.8× 173 2.3× 60 1.0× 76 1.4× 32 0.7× 33 509
Juan Turati Argentina 8 140 0.9× 110 1.5× 126 2.1× 93 1.7× 28 0.6× 11 347

Countries citing papers authored by Pablo Berríos‐Cárcamo

Since Specialization
Citations

This map shows the geographic impact of Pablo Berríos‐Cárcamo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Berríos‐Cárcamo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Berríos‐Cárcamo more than expected).

Fields of papers citing papers by Pablo Berríos‐Cárcamo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Berríos‐Cárcamo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Berríos‐Cárcamo. The network helps show where Pablo Berríos‐Cárcamo may publish in the future.

Co-authorship network of co-authors of Pablo Berríos‐Cárcamo

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Berríos‐Cárcamo. A scholar is included among the top collaborators of Pablo Berríos‐Cárcamo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Berríos‐Cárcamo. Pablo Berríos‐Cárcamo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tobar, Hugo E., Marı́a Elena Quintanilla, Paola Morales, et al.. (2025). Gut Microbiota‐Derived Extracellular Vesicles Influence Alcohol Intake Preferences in Rats. Journal of Extracellular Vesicles. 14(3). e70059–e70059. 3 indexed citations
2.
Berríos‐Cárcamo, Pablo, et al.. (2024). Two-Month Voluntary Ethanol Consumption Promotes Mild Neuroinflammation in the Cerebellum but Not in the Prefrontal Cortex, Hippocampus, or Striatum of Mice. International Journal of Molecular Sciences. 25(8). 4173–4173. 3 indexed citations
3.
Berríos‐Cárcamo, Pablo, et al.. (2024). Mesenchymal stem cells as a promising therapy for alcohol use disorder. International review of neurobiology. 178. 179–211.
4.
Berríos‐Cárcamo, Pablo, Álex Handy, Daniela Santapau, et al.. (2024). Methadone directly impairs central nervous system cells in vitro. Scientific Reports. 14(1). 16978–16978. 2 indexed citations
5.
Quintanilla, Marı́a Elena, Daniela Santapau, Glauben Landskron, et al.. (2024). Intragastric administration of short chain fatty acids greatly reduces voluntary ethanol intake in rats. Scientific Reports. 14(1). 29260–29260. 2 indexed citations
6.
Quintanilla, Marı́a Elena, Mario Rivera‐Meza, Pablo Berríos‐Cárcamo, & Bruce K. Cassels. (2023). Reduction of nicotine and ethanol intake in alcohol-preferring (UChB) female rats by the α4β2 nicotinic acetylcholine receptor partial agonists 5-bromocytisine and cytisine. Drug and Alcohol Dependence. 250. 110900–110900. 2 indexed citations
7.
Ponce, Carolina A., Pablo Berríos‐Cárcamo, Daniela Santapau, et al.. (2023). Amelioration of morphine withdrawal syndrome by systemic and intranasal administration of mesenchymal stem cell‐derived secretome in preclinical models of morphine dependence. CNS Neuroscience & Therapeutics. 30(4). e14517–e14517. 6 indexed citations
8.
Quintanilla, Marı́a Elena, Paola Morales, Daniela Santapau, et al.. (2023). Chronic Voluntary Morphine Intake Is Associated with Changes in Brain Structures Involved in Drug Dependence in a Rat Model of Polydrug Use. International Journal of Molecular Sciences. 24(23). 17081–17081. 5 indexed citations
9.
Quintanilla, Marı́a Elena, Paola Morales, Pablo Berríos‐Cárcamo, et al.. (2022). Effect of human mesenchymal stem cell secretome administration on morphine self-administration and relapse in two animal models of opioid dependence. Translational Psychiatry. 12(1). 462–462. 4 indexed citations
10.
Charkoftaki, Georgia, Pablo Berríos‐Cárcamo, David J. Orlicky, et al.. (2022). Liver metabolomics identifies bile acid profile changes at early stages of alcoholic liver disease in mice. Chemico-Biological Interactions. 360. 109931–109931. 13 indexed citations
11.
Berríos‐Cárcamo, Pablo, Daniela Santapau, Paola Morales, et al.. (2022). A Novel Morphine Drinking Model of Opioid Dependence in Rats. International Journal of Molecular Sciences. 23(7). 3874–3874. 12 indexed citations
12.
Berríos‐Cárcamo, Pablo, Marı́a Elena Quintanilla, Paola Morales, et al.. (2020). Oxidative Stress and Neuroinflammation as a Pivot in Drug Abuse. A Focus on the Therapeutic Potential of Antioxidant and Anti-Inflammatory Agents and Biomolecules. Antioxidants. 9(9). 830–830. 62 indexed citations
13.
Israel, Yedy, Marı́a Elena Quintanilla, Fernando Ezquer, et al.. (2019). Aspirin and N‐acetylcysteine co‐administration markedly inhibit chronic ethanol intake and block relapse binge drinking: Role of neuroinflammation‐oxidative stress self‐perpetuation. Addiction Biology. 26(1). e12853–e12853. 31 indexed citations
14.
Quintanilla, Marı́a Elena, Fernando Ezquer, Paola Morales, et al.. (2019). Intranasal mesenchymal stem cell secretome administration markedly inhibits alcohol and nicotine self-administration and blocks relapse-intake: mechanism and translational options. Stem Cell Research & Therapy. 10(1). 205–205. 29 indexed citations
15.
Marshall, Stephanie, Ying Chen, Surendra Singh, et al.. (2018). Engineered Animal Models Designed for Investigating Ethanol Metabolism, Toxicity and Cancer. Advances in experimental medicine and biology. 1032. 203–221. 6 indexed citations
16.
Berríos‐Cárcamo, Pablo, Marı́a Elena Quintanilla, Mario Herrera‐Marschitz, et al.. (2017). Racemic Salsolinol and its Enantiomers Act as Agonists of the μ-Opioid Receptor by Activating the Gi Protein-Adenylate Cyclase Pathway. Frontiers in Behavioral Neuroscience. 10. 253–253. 14 indexed citations
17.
Quintanilla, Marı́a Elena, et al.. (2016). Beyond the “First Hit”: Marked Inhibition byN-Acetyl Cysteine of Chronic Ethanol Intake But Not of Early Ethanol Intake. Parallel Effects on Ethanol-Induced Saccharin Motivation. Alcoholism Clinical and Experimental Research. 40(5). 1044–1051. 35 indexed citations
18.
Quintanilla, Marı́a Elena, Mario Rivera‐Meza, Pablo Berríos‐Cárcamo, et al.. (2015). (R)-Salsolinol, a product of ethanol metabolism, stereospecifically induces behavioral sensitization and leads to excessive alcohol intake. Addiction Biology. 21(6). 1063–1071. 29 indexed citations
19.
Quintanilla, Marı́a Elena, Mario Rivera‐Meza, Pablo Berríos‐Cárcamo, et al.. (2014). Salsolinol, free of isosalsolinol, exerts ethanol-like motivational/sensitization effects leading to increases in ethanol intake. Alcohol. 48(6). 551–559. 30 indexed citations
20.
Berríos‐Cárcamo, Pablo, et al.. (2012). Salsolinol and isosalsolinol: Condensation products of acetaldehyde and dopamine. Separation of their enantiomers in the presence of a large excess of dopamine. Journal of Pharmaceutical and Biomedical Analysis. 63. 170–174. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026